Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaycie Deyle

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Chimia|June 27, 2018
Drugs Based on de <i>novo</i>-developed Peptides are Coming of Age mune is aKaycie Deyle, Christian Heinis
Current Opinion in Chemical Biology|March 2, 2017
Cyclic peptide therapeutics: past, present and futureAlessandro Zorzi, Kaycie Deyle, Christian Heinis
Accounts of Chemical Research|July 19, 2017
Phage Selection of Cyclic Peptides for Application in Research and Drug DevelopmentKaycie Deyle, Xu-Dong Kong, Christian Heinis
Nature Communications|July 18, 2017
Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptidesAlessandro Zorzi, Simon J Middendorp, Jonas Wilbs, et al.
Nature Chemistry|May 2, 2018
Cyclization of peptides with two chemical bridges affords large scaffold diversitiesSangram S Kale, Camille Villequey, Xu-Dong Kong, et al.
Nature Biomedical Engineering|May 13, 2020
De novo development of proteolytically resistant therapeutic peptides for oral administrationXu-Dong Kong, Jun Moriya, Vanessa Carle, et al.
Angewandte Chemie (International Ed. in English)|June 29, 2019
Engineered Peptide Macrocycles Can Inhibit Matrix Metalloproteinases with High SelectivityKhan Maola, Jonas Wilbs, Jeremy Touati, et al.
Chemical Science|June 7, 2021
Macrocycle synthesis strategy based on step-wise "adding and reacting" three components enables screening of large combinatorial librariesGanesh K Mothukuri, Sangram S Kale, Carl L Stenbratt, et al.
Nature Communications|August 6, 2020
Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungsJonas Wilbs, Xu-Dong Kong, Simon J Middendorp, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Chimia|June 27, 2018
Drugs Based on de <i>novo</i>-developed Peptides are Coming of Age mune is aKaycie Deyle, Christian Heinis
Current Opinion in Chemical Biology|March 2, 2017
Cyclic peptide therapeutics: past, present and futureAlessandro Zorzi, Kaycie Deyle, Christian Heinis
Accounts of Chemical Research|July 19, 2017
Phage Selection of Cyclic Peptides for Application in Research and Drug DevelopmentKaycie Deyle, Xu-Dong Kong, Christian Heinis
Nature Communications|July 18, 2017
Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptidesAlessandro Zorzi, Simon J Middendorp, Jonas Wilbs, et al.
Nature Chemistry|May 2, 2018
Cyclization of peptides with two chemical bridges affords large scaffold diversitiesSangram S Kale, Camille Villequey, Xu-Dong Kong, et al.
Nature Biomedical Engineering|May 13, 2020
De novo development of proteolytically resistant therapeutic peptides for oral administrationXu-Dong Kong, Jun Moriya, Vanessa Carle, et al.
Angewandte Chemie (International Ed. in English)|June 29, 2019
Engineered Peptide Macrocycles Can Inhibit Matrix Metalloproteinases with High SelectivityKhan Maola, Jonas Wilbs, Jeremy Touati, et al.
Chemical Science|June 7, 2021
Macrocycle synthesis strategy based on step-wise "adding and reacting" three components enables screening of large combinatorial librariesGanesh K Mothukuri, Sangram S Kale, Carl L Stenbratt, et al.
Nature Communications|August 6, 2020
Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungsJonas Wilbs, Xu-Dong Kong, Simon J Middendorp, et al.
Pageof 1